Mirum Pharmaceuticals (MIRM) Operating Leases (2020 - 2025)
Historic Operating Leases for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Q3 2025 value amounting to $9.4 million.
- Mirum Pharmaceuticals' Operating Leases fell 590.83% to $9.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.4 million, marking a year-over-year decrease of 590.83%. This contributed to the annual value of $8.0 million for FY2024, which is 119205.83% up from last year.
- Mirum Pharmaceuticals' Operating Leases amounted to $9.4 million in Q3 2025, which was down 590.83% from $10.0 million recorded in Q2 2025.
- Mirum Pharmaceuticals' 5-year Operating Leases high stood at $10.0 million for Q3 2024, and its period low was $617000.0 during Q4 2023.
- In the last 5 years, Mirum Pharmaceuticals' Operating Leases had a median value of $1.9 million in 2021 and averaged $3.9 million.
- In the last 5 years, Mirum Pharmaceuticals' Operating Leases plummeted by 5091.49% in 2023 and then surged by 119205.83% in 2024.
- Mirum Pharmaceuticals' Operating Leases (Quarter) stood at $1.9 million in 2021, then plummeted by 33.95% to $1.3 million in 2022, then tumbled by 50.91% to $617000.0 in 2023, then surged by 1192.06% to $8.0 million in 2024, then rose by 17.86% to $9.4 million in 2025.
- Its Operating Leases was $9.4 million in Q3 2025, compared to $10.0 million in Q2 2025 and $8.6 million in Q1 2025.